{'fraction_non_alphanumeric': 0.03292181069958848, 'fraction_numerical': 0.0024691358024691358, 'mean_word_length': 6.028901734104046, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Adaptive Immunity Driven Inflammation and Cardiovascular Disease.

The adaptive immune response has recently emerged as an important factor in a wide variety of cardiovascular disorders including atherosclerosis, hypertension, cardiac remodeling, and heart failure; however, its role is not fully understood. Since an assortment of innate responsive cells (e.g. neutrophils, monocytes/macrophages) coordinate with adaptive immunity (e.g. T-cells, dendritic cells, B-cells), the temporal response and descriptions pertinent to the cellular phenotype, and inflammation processes in general, need additional investigation, clarification, and consensus particularly in cardiovascular disease. This "Perspectives" article reviews the contributions of 15 articles (including 7 reviews) published in the American Journal of Physiology-Heart and Circulatory Physiology in response to the Call for Papers Here, we summarize the crucial reported findings at the cardiac, vascular, immune, and molecular levels, and discuss the translational feasibility and benefits of future prospective research into the adaptive immune response. Readers are encouraged to evaluate the data, and learn from this collection of novel studies.